Economic benefits of teaching patients with chronic obstructive pulmonary disease about their illness

The Lancet

Volumn 339, Issue 8808, 1992, Pages 1517-1520

  Tougaard, L ^a   Sorknaes, A ^a   Ellegaard, H ^a   Krone, T ^b   Pastma Group, ^c  

^a Department of Anaesthesiology   (Denmark)

^b Fyns Country Department for Hospital Administration ^*  (Denmark)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR STIMULATING AGENT; METHYLXANTHINE; STEROID;

ADULT; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL TRIAL; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; DENMARK; FEMALE; HEALTH CARE MANAGEMENT; HUMAN; MAJOR CLINICAL STUDY; MALE; ORAL DRUG ADMINISTRATION; PATIENT COUNSELING; PATIENT EDUCATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

AGED; AGED, 80 AND OVER; COMPARATIVE STUDY; FOLLOW-UP STUDIES; HOSPITALIZATION; HUMAN; LUNG DISEASES, OBSTRUCTIVE; MIDDLE AGE; PATIENT EDUCATION; PRIMARY HEALTH CARE; RANDOM ALLOCATION; SMOKING;

EID: 0026651084     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/0140-6736(92)91274-C     Document Type: Article

References (3)

1. Minimization: a new method of assigning patients treatment and control groups
2. Education of adult patients at an "asthma school": effects on quality of life, knowledge and need for nursing
3. Stuegang afskaffet